Skip to main content
Journal cover image

Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.

Publication ,  Journal Article
Szerlip, M; Zajarias, A; Vemalapalli, S; Brennan, M; Dai, D; Maniar, H; Lindman, BR; Brindis, R; Carroll, JD; Hamandi, M; Edwards, FH; Mack, M ...
Published in: J Am Coll Cardiol
June 11, 2019

BACKGROUND: In patients with end-stage renal disease (ESRD), surgical aortic valve replacement is associated with higher early and late mortality, and adverse outcomes compared with patients without renal disease. Transcatheter aortic valve replacement (TAVR) offers another alternative, but there are limited reported outcomes. OBJECTIVES: The purpose of this study was to determine the outcomes of TAVR in patients with ESRD. METHODS: Among the first 72,631 patients with severe aortic stenosis (AS) treated with TAVR enrolled in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT (Transcatheter Valve Therapies) registry, 3,053 (4.2%) patients had ESRD and were compared with patients who were not on dialysis for demographics, risk factors, and outcomes. RESULTS: Compared with the nondialysis patients, ESRD patients were younger (76 years vs. 83 years; p < 0.01) and had higher rates of comorbidities leading to a higher STS predicted risk of mortality (median 13.5% vs. 6.2%; p < 0.01). ESRD patients had a higher in-hospital mortality (5.1% vs. 3.4%; p < 0.01), although the observed to expected ratio was lower (0.32 vs. 0.44; p < 0.01). ESRD patients also had a similar rate of major vascular complications (4.5% vs. 4.6%; p = 0.86), but a higher rate of major bleeding (1.4% vs. 1.0%; p = 0.03). The 1-year mortality was significantly higher in dialysis patients (36.8% vs. 18.7%; p < 0.01). CONCLUSIONS: Patients undergoing TAVR with ESRD are at higher risk and had higher in-hospital mortality and bleeding, but similar vascular complications, when compared with those who are not dialysis dependent. The 1-year survival raises concerns regarding diminished benefit in this population. TAVR should be used judiciously after full discussion of the risk-benefit ratio in patients on dialysis.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

June 11, 2019

Volume

73

Issue

22

Start / End Page

2806 / 2815

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Risk
  • Renal Dialysis
  • Registries
  • Reference Values
  • Male
  • Kidney Failure, Chronic
  • Humans
  • Hospital Mortality
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Szerlip, M., Zajarias, A., Vemalapalli, S., Brennan, M., Dai, D., Maniar, H., … Mack, M. (2019). Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. J Am Coll Cardiol, 73(22), 2806–2815. https://doi.org/10.1016/j.jacc.2019.03.496
Szerlip, Molly, Alan Zajarias, Sreekanth Vemalapalli, Matthew Brennan, Dadi Dai, Hersh Maniar, Brian R. Lindman, et al. “Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.J Am Coll Cardiol 73, no. 22 (June 11, 2019): 2806–15. https://doi.org/10.1016/j.jacc.2019.03.496.
Szerlip M, Zajarias A, Vemalapalli S, Brennan M, Dai D, Maniar H, et al. Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. J Am Coll Cardiol. 2019 Jun 11;73(22):2806–15.
Szerlip, Molly, et al. “Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.J Am Coll Cardiol, vol. 73, no. 22, June 2019, pp. 2806–15. Pubmed, doi:10.1016/j.jacc.2019.03.496.
Szerlip M, Zajarias A, Vemalapalli S, Brennan M, Dai D, Maniar H, Lindman BR, Brindis R, Carroll JD, Hamandi M, Edwards FH, Grover F, O’Brien S, Peterson E, Rumsfeld JS, Shahian D, Tuzcu EM, Holmes D, Thourani VH, Mack M. Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. J Am Coll Cardiol. 2019 Jun 11;73(22):2806–2815.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

June 11, 2019

Volume

73

Issue

22

Start / End Page

2806 / 2815

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Risk
  • Renal Dialysis
  • Registries
  • Reference Values
  • Male
  • Kidney Failure, Chronic
  • Humans
  • Hospital Mortality